ACAMBIS PLC - Acquisition
ACAMBIS PLC - Acquisition
5/10/2005
PR Newswire UK Disclose
Acambis expands manufacturing capability with acquisition of US-based fill/
finish facility
Cambridge, UK and Cambridge, Massachusetts - 10 May 2005 - Acambis plc
("Acambis") (LSE: ACM, NASDAQ: ACAM) announces that it has acquired a US-based
fill/finish facility from BioReliance Corporation ("BioReliance"), a wholly
owned subsidiary of Invitrogen Corporation (NASDAQ: IVGN).
With the acquisition, Acambis intends to develop a commercial-scale fill/finish
capability suitable for many of the vaccines in its development pipeline, which
includes the ACAM2000 and MVA3000 smallpox ...
?Read the Full Article, Sign up today?
Votes:9
Comments: 0